Recap: Rigel Pharmaceuticals Q1 Earnings

Rigel Pharmaceuticals RIGL reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:01 PM.

Here's what investors need to know about the announcement.

Rigel Pharmaceuticals missed estimated earnings by 14.29%, reporting an EPS of $-0.16 versus an estimate of $-0.14.

Revenue was down $64.28 million from the same period last year.

Last quarter the company beat on EPS by $0.02 which was followed by a 21.12% increase in the share price the next day.

Here's a look at Rigel Pharmaceuticals's past performance:

Quarter	Q4 2021	Q3 2021	Q2 2021	Q1 2021
EPS Estimate	-0.13	-0.10	-0.11
EPS Actual	-0.11	-0.12	-0.08	0.22
Revenue Estimate	21.90M	23.56M	20.37M	31.05M
Revenue Actual	20.41M	21.54M	26.27M	81.02M

To track all earnings releases for Rigel Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar